The landscape of dementia diagnosis has progressed substantially with the appearance of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-centered tests that will detect Alzheimer's pathology several years in advance of indications arise. While these technological developments signify impressive progress in knowledge neur